Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279 Consecutive patients with head and ...
Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...
Primary immunodeficiency disorders (PIDs) are a heterogeneous group of disorders characterized, as the name suggests, by deficiencies (abnormal, poor or absent function) in the immune system. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results